Serpin fusion polypeptides and methods of use thereof
AssigneeInhibrx, Inc.
InventorsBrendan P. Eckelman, John C. Timmer, Peter L. Nguy, Grant B. Guenther, Quinn Deveraux
Life of this patent
Estimating the term…
Loading patent…
AssigneeInhibrx, Inc.
InventorsBrendan P. Eckelman, John C. Timmer, Peter L. Nguy, Grant B. Guenther, Quinn Deveraux
Estimating the term…
This invention relates to molecules, particularly polypeptides, more particularly fusion proteins that include a serpin polypeptide or an amino acid sequence that is derived from a serpin and second polypeptide comprising of at least one the following: an Fc polypeptide or an amino acid sequence that is derived from an Fc polypeptide; a cytokine targeting polypeptide or a sequence derived from a cytokine targeting polypeptide; a WAP domain containing polypeptide or a sequence derived from a WAP containing polypeptide; and an albumin polypeptide or an amino acid sequence that is derived from a serum albumin polypeptide. This invention also relates to methods of using such molecules in a variety of therapeutic and diagnostic indications, as well as methods of producing such molecules.
An isolated fusion protein comprising at least one human serpin polypeptide operably linked to a second polypeptide wherein the second polypeptide comprises at least one the following:
An isolated fusion protein comprising at least one alpha-1 antitrypsin (AAT) polypeptide operably linked to a second polypeptide of at least one of the following:
An isolated fusion protein comprising at least one alpha-1 antitrypsin (AAT) polypeptide operably linked to a second polypeptide of at least one of the following:
The isolated fusion protein of claim 47, wherein the albumin binding polypeptide is Domain 3 of Streptococcal Protein G or a sequence derived from Domain 3 of Streptococcal Protein G.
Dependencies are inferred from the claim text.